Highlights: -EVAR 1 trial 15-year follow-up published: Lifelong surveillance of EVAR and prompt reintervention are paramount -IVUS may be a more accurate method than venography for assessing lesion severity and proper venous stent size -Fabio Verzini: EVAR devices -Armando Mansilha: Vein thrombosis -Profile: Vincent Riambau
[pdfviewer width=”100%” height=”940px” beta=”true”]http://vascularnews.com/wp-content/uploads/sites/7/2016/11/72-VN-EU-low-res.pdf[/pdfviewer]
